Introduction
On March 4, 2025, a significant milestone in international public health was achieved at the World Health Organization (WHO) Regional Office in Copenhagen, Denmark. The World Health Organization and the Swiss Confederation formally signed the renewal of their Country Cooperation Strategy (CCS) for the 2024–2028 period. This agreement solidifies a unique, long-standing partnership between a global health authority and one of its most pivotal host nations, signaling a shared commitment to addressing both domestic health challenges and the complex, borderless threats facing the global community.
The renewal is more than a bureaucratic formality; it represents a strategic alignment designed to navigate the post-pandemic landscape, address the rise of non-communicable diseases, and leverage Switzerland’s unique position as a global hub for health innovation and governance.
The Core Facts: A Strategic Framework
The WHO-Switzerland Cooperation Strategy 2024–2028 serves as a high-level roadmap defining how the two entities will coordinate their technical expertise and policy efforts. Unlike standard agreements often reserved for developing nations, this strategy highlights Switzerland’s role as a leader in health policy.
The partnership focuses on several key pillars:
- Strengthening Health Security: Enhancing preparedness for future pandemics and health emergencies.
- Innovation in Global Health: Capitalizing on Switzerland’s status as a leader in biotechnology and pharmaceuticals.
- Equity and Access: Ensuring that medical advancements are not just developed in Switzerland, but accessible to the global population.
- Policy Coherence: Aligning Swiss domestic health policies with international standards set by the WHO to ensure a "Health in All Policies" approach.
By formalizing this strategy, both parties have committed to a structured dialogue that allows for rapid response to emerging crises while maintaining a long-term focus on sustainable health system development.
A Chronology of Collaboration
To understand the weight of this 2024–2028 agreement, one must look at the evolution of the relationship between these two entities.
2013: The Pioneering Pilot
In 2013, Switzerland made history by becoming the first high-income country in the WHO European Region to initiate a formal Country Cooperation Strategy. At the time, this was a bold move. Traditionally, CCS frameworks were tools used by the WHO to support low- and middle-income nations in strengthening their healthcare infrastructure. Switzerland’s decision to adopt this model signaled a paradigm shift: recognizing that even highly developed, wealthy nations require a structured, collaborative relationship with the WHO to remain at the cutting edge of global health governance.
2022: The Decision to Renew
Following a decade of success, both parties recognized the need for a fundamental refresh. The COVID-19 pandemic had exposed vulnerabilities in even the most advanced health systems. In 2022, leadership from the WHO and the Swiss Federal Office of Public Health (FOPH) began consultations to evaluate the successes and limitations of the previous decade and to draft a new mandate that would reflect the geopolitical and epidemiological realities of the mid-2020s.
March 4, 2025: Formalization in Copenhagen
The culmination of these discussions occurred in Copenhagen, where Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health, signed the document. The signing event was not merely a ceremonial act; it was a public declaration of the renewed synergy between the two organizations.
Supporting Data: Why This Partnership Matters
The significance of this cooperation is best understood through the lens of Switzerland’s unique position in the global health ecosystem.
The Geneva Hub
Geneva is arguably the global capital of health diplomacy. It hosts the WHO headquarters, the Gavi Vaccine Alliance, the Global Fund, and numerous other health-focused NGOs. This geographic concentration of power makes the partnership between the Swiss government and the WHO a linchpin for global decision-making.
The Global BioHub System
A critical component of this ongoing cooperation is the WHO BioHub System, an initiative launched to facilitate the rapid sharing of biological materials with epidemic or pandemic potential. Switzerland has been a primary supporter of this system, providing the necessary infrastructure and legal framework to ensure that when a new pathogen is identified, samples can be analyzed safely and quickly. This collaboration serves as a template for how national infrastructure can be leveraged for global collective security.
Economic and Research Contribution
Switzerland consistently ranks among the top contributors to the WHO’s voluntary funds. However, the value of the partnership goes beyond financial input; it is a knowledge exchange. By aligning its research and development policies with the WHO’s R&D Blueprint, Switzerland ensures that its academic and private-sector innovations are directed toward solving the most pressing global health needs, rather than just the most profitable ones.
Official Responses: Aligning Visions
The partnership is rooted in mutual respect and shared objectives. During the signing ceremony, the rhetoric emphasized the transition from "cooperation" to "active partnership."
Dr. Hans Henri P. Kluge, WHO Regional Director for Europe:
Dr. Kluge highlighted that the strategy is a testament to the "indispensable nature of multilateralism." He noted that Switzerland’s proactive approach to health security serves as a model for the entire European region. By embedding WHO guidance into national law, Switzerland ensures that its citizens benefit from the highest standards of evidence-based medicine, while also setting a benchmark for other European nations to follow.
Ambassador Barbara Schedler:
Representing the Swiss Federal Office of Public Health, Ambassador Schedler emphasized that Switzerland’s commitment to the WHO is a core component of its foreign policy. "Global health is not a peripheral issue for Switzerland; it is a national security priority," she remarked. The Ambassador pointed out that the renewal reflects a shift toward more agile and flexible collaboration, allowing both parties to pivot quickly when faced with sudden crises, such as climate-related health challenges or outbreaks of infectious diseases.
Implications: The Road Ahead (2025–2028)
The renewal of the CCS is not just a look back at successes; it is a strategic blueprint for the future. Several implications of this agreement are expected to shape the next four years:
1. Strengthening Pandemic Preparedness
The world remains in a fragile state post-COVID-19. The agreement specifically prioritizes the strengthening of the International Health Regulations (IHR) and the ongoing negotiations surrounding a potential global pandemic treaty. Switzerland’s role as a neutral, diplomatic mediator will be vital in ensuring that member states find common ground on issues of data sharing and equitable vaccine distribution.
2. Addressing the "Health in All Policies" Approach
The strategy emphasizes that health is not merely the absence of disease, but a byproduct of economic, social, and environmental factors. By working with the WHO, Switzerland intends to integrate health considerations into its environmental, trade, and education policies. This includes addressing the health impacts of climate change, which has become a focal point of the WHO European Region’s agenda.
3. Digital Health and AI
As artificial intelligence begins to revolutionize medical diagnostics and epidemiology, the WHO-Switzerland partnership will likely lead the way in setting ethical standards for digital health. Switzerland’s robust regulatory environment provides the perfect sandbox for testing WHO-approved digital health tools before they are rolled out to resource-limited settings.
4. Sustaining the BioHub
The partnership ensures the long-term sustainability of the BioHub system. By formalizing this, the WHO is guaranteed a reliable, high-tech hub for pathogen analysis, which is essential for the next decade of public health surveillance.
Conclusion
The WHO-Switzerland Country Cooperation Strategy 2024–2028 is a sophisticated agreement that reflects the maturity of a decade-long partnership. It moves beyond simple technical assistance to foster a deep, integrated collaboration that leverages Switzerland’s scientific and diplomatic prowess for the benefit of global health.
As the world faces an era of uncertainty—defined by climate change, the rapid evolution of pathogens, and shifting geopolitical alliances—this agreement provides a necessary foundation of stability. For the next four years, the collaboration between the WHO and Switzerland will serve as a beacon of what is possible when national interests and global responsibilities are harmonized. It is a partnership that recognizes that in the realm of public health, no country is truly secure until all countries are secure.
For those interested in the granular details of this strategic vision, the full text of the WHO-Switzerland Country Cooperation Strategy 2024–2028 is available through the WHO/Europe portal, providing a roadmap for stakeholders, policymakers, and the global public on how these two entities intend to navigate the challenges of the coming years.
About the Author
